Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 117
11
Diseases
27
Unique genes
0.291
Avg. similarity score
ATR-X-related syndrome
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
ATR-X-related syndrome
Alpha thalassemia x-linked intellectual disability
Atr-x syndrome
Intellectual developmental disorder hypotonic x-linked
X-linked alpha-thalassemia-intellectual disability syndrome
Penile disease
Thoracic disease
Say meyer syndrome
Urinary system disease
non-syndromic X-linked intellectual disability
Urinary tract obstruction
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| ATR-X-related syndrome | 6 | 6 | 1 |
| Alpha thalassemia x-linked intellectual disability | 6 | 6 | 1 |
| Atr-x syndrome | 6 | 6 | 1 |
| Intellectual developmental disorder hypotonic x-linked | 6 | 6 | 2 |
| X-linked alpha-thalassemia-intellectual disability syndrome | 6 | 6 | 1 |
| Penile disease | 5 | 5 | 6 |
| Thoracic disease | 4 | 4 | 3 |
| Say meyer syndrome | 2 | 2 | 1 |
| Urinary system disease | 2 | 2 | 15 |
| non-syndromic X-linked intellectual disability | 2 | 2 | 7 |
| Urinary tract obstruction | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ATRX | 7 / 11 | Alpha thalassemia x-linked intellectual disability, Atr-x syndrome, ATR-X-related syndrome, Intellectual developmental disorder hypotonic x-linked and 3 more |
| HUWE1 | 3 / 11 | Intellectual developmental disorder hypotonic x-linked, non-syndromic X-linked intellectual disability, Say meyer syndrome |
| LRRC75A | 2 / 11 | Penile disease, Urinary system disease |
| RIOX2 | 2 / 11 | Urinary system disease, Urinary tract obstruction |
| SLC9A9 | 2 / 11 | Penile disease, Urinary system disease |
| ZNF287 | 2 / 11 | Penile disease, Urinary system disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Defective SLC9A9 causes autism 16 (AUTS16) | Reactome | 1 / 1 | 445× | 2.25e-3 | 2.48e-2 ✓ sig. |
| Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD) | Reactome | 1 / 2 | 222× | 4.49e-3 | 4.08e-2 ✓ sig. |
| Peptide hormone biosynthesis | Reactome | 1 / 2 | 222× | 4.49e-3 | 4.08e-2 ✓ sig. |
| ARL13B-mediated ciliary trafficking of INPP5E | Reactome | 1 / 3 | 148× | 6.73e-3 | 5.32e-2 |
| Intracellular metabolism of fatty acids regulates insulin secretion | Reactome | 1 / 3 | 148× | 6.73e-3 | 5.32e-2 |
| Opioid Signalling | Reactome | 1 / 3 | 148× | 6.73e-3 | 5.32e-2 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | Reactome | 1 / 4 | 111× | 8.96e-3 | 6.42e-2 |
| Adipocytokine signaling pathway | KEGG | 2 / 70 | 12.7× | 1.07e-2 | 7.16e-2 |
| PPAR signaling pathway | KEGG | 2 / 76 | 11.7× | 1.25e-2 | 7.82e-2 |
| Sodium/Proton exchangers | Reactome | 1 / 9 | 49.4× | 2.01e-2 | 1.03e-1 |
| Glucocorticoid biosynthesis | Reactome | 1 / 10 | 44.5× | 2.23e-2 | 1.09e-1 |
| Androgen biosynthesis | Reactome | 1 / 11 | 40.4× | 2.45e-2 | 1.15e-1 |
| Cell-extracellular matrix interactions | Reactome | 1 / 12 | 37.1× | 2.67e-2 | 1.21e-1 |
| Activation of Ca-permeable Kainate Receptor | Reactome | 1 / 12 | 37.1× | 2.67e-2 | 1.21e-1 |
| Trafficking of GluR2-containing AMPA receptors | Reactome | 1 / 17 | 26.2× | 3.76e-2 | 1.46e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to inositol | GO:1902140 | 2 / 4 | 346× | 1.20e-5 | 6.02e-4 ✓ sig. |
| establishment or maintenance of epithelial cell apical/basal polarity | GO:0045197 | 2 / 29 | 47.7× | 7.97e-4 | 1.30e-2 ✓ sig. |
| cellular pigmentation | GO:0033059 | 1 / 1 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| positive regulation of oxytocin production | GO:0140668 | 1 / 1 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| negative regulation of prostaglandin secretion | GO:0032307 | 1 / 1 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| protein localization to ciliary inversin compartment | GO:1904108 | 1 / 1 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| post-embryonic forelimb morphogenesis | GO:0035128 | 1 / 2 | 346× | 2.89e-3 | 2.76e-2 ✓ sig. |
| negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric | GO:1904908 | 1 / 2 | 346× | 2.89e-3 | 2.76e-2 ✓ sig. |
| neurotransmitter receptor transport postsynaptic membrane to endosome | GO:0098968 | 1 / 2 | 346× | 2.89e-3 | 2.76e-2 ✓ sig. |
| regulation of opioid receptor signaling pathway | GO:2000474 | 1 / 2 | 346× | 2.89e-3 | 2.76e-2 ✓ sig. |
| positive regulation of neutrophil mediated killing of fungus | GO:0070965 | 1 / 2 | 346× | 2.89e-3 | 2.76e-2 ✓ sig. |
| regulation of corticosterone secretion | GO:2000852 | 1 / 2 | 346× | 2.89e-3 | 2.76e-2 ✓ sig. |
| canonical NF-kappaB signal transduction | GO:0007249 | 2 / 62 | 22.3× | 3.60e-3 | 3.13e-2 ✓ sig. |
| purine nucleoside metabolic process | GO:0042278 | 1 / 3 | 231× | 4.33e-3 | 3.40e-2 ✓ sig. |
| peptidyl-glutamate ADP-deribosylation | GO:0140291 | 1 / 3 | 231× | 4.33e-3 | 3.40e-2 ✓ sig. |